絞り込み

16532

広告

「elotuzumab」の検索結果

198件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Carfilzomib.

Pomalidomide.

The Multiple Myeloma Drug Pipeline-2018: A Review of Small Molecules and Their Therapeutic Targets.

Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab.

Maintenance and continuous therapy for multiple myeloma.

Interference of Therapeutic Monoclonal Antibodies With Routine Serum Protein Electrophoresis and Immunofixation in Patients With Myeloma: Frequency and Duration of Detection of Daratumumab and Elotuzumab.

[Multiple myeloma: update on pathophysiology and management].

Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016).

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study.

A look at treatment strategies for relapsed multiple myeloma.

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.

Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma.

Current use of monoclonal antibodies in the treatment of multiple myeloma.

[The most recent developments in diagnosis and treatment of multiple myeloma].

Antibody dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab.

Elotuzumab-induced interstitial lung disease: the first case report.

Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapy.

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4).

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります